Literature DB >> 16437481

Endoscopic mucosal resection for early gastric cancer.

Y P Wang1, C Bennett, T Pan.   

Abstract

BACKGROUND: The treatment of early gastric cancer (EGC) using an endoscopy, namely, endoscopic mucosal resection (EMR), has been adopted for about 20 years, but the effectiveness and the safety of the modality are still controversial. The quality of these trials has not been assessed systematically.
OBJECTIVES: The purpose of this review was to compare the effectiveness and the safety of EMR with gastrectomy for the treatment of EGC. SEARCH STRATEGY: Searches were conducted on the Cochrane Central Register of Controlled Trials - CENTRAL (which includes the Cochrane Upper Gastrointestinal and Pancreatic Diseases Group Trials Register) on The Cochrane Library (Issue 1 2005) MEDLINE (1966 to March 2005) and EMBASE (1980 to March 2005), CINAHL (1985-March 2005) and CBM (Chinese BioMedical Database 1982 -2002). Reference lists from trials selected by electronic searching were handsearched to identify further relevant trials. Published abstracts from conference proceedings from the United European Gastroenterology Week (published in Gut) and Digestive Disease Week (published in Gastroenterology) were handsearched. Members of the Cochrane UGPD Group, and experts in the field were contacted and asked to provide details of outstanding clinical trials and any relevant unpublished materials SELECTION CRITERIA: All randomised controlled trials of EGC patients involving a treatment arm of EMR and a comparison arm of gastrectomy were to be included, but no RCTs were found. DATA COLLECTION AND ANALYSIS: Three reviewers (YP Wang, C Bennett and T Pan) independently assessed the eligibility of potential trials and extracted the data. MAIN
RESULTS: There are no included randomised control trials for the systematic review. Available evidence derived from non-randomised controlled trials is discussed in the main text of this review. AUTHORS'
CONCLUSIONS: There is a lack of randomised controlled trials in which EMR is compared with gastrectomy for EGC. There is a need for well designed randomised controlled trials to determine the effects of EMR compared to gastrectomy.

Entities:  

Mesh:

Year:  2006        PMID: 16437481     DOI: 10.1002/14651858.CD004276.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  6 in total

Review 1.  Interventional upper endoscopy: the adult perspective.

Authors:  Tonya Kaltenbach; Seth Crockett; George Triadafilopoulos
Journal:  Curr Gastroenterol Rep       Date:  2006-12

Review 2.  Current role of minimally invasive approaches in the treatment of early gastric cancer.

Authors:  Abraham El-Sedfy; Savtaj S Brar; Natalie G Coburn
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

3.  Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer.

Authors:  Jennifer M Yeh; Chin Hur; Karen M Kuntz; Majid Ezzati; Sue J Goldie
Journal:  Cancer       Date:  2010-06-15       Impact factor: 6.860

4.  Gastric cancer.

Authors:  Henk H Hartgrink; Edwin P M Jansen; Nicole C T van Grieken; Cornelis J H van de Velde
Journal:  Lancet       Date:  2009-07-20       Impact factor: 79.321

5.  Clinicopathological characteristics and treatment strategies in early gastric cancer: a retrospective cohort study.

Authors:  Hiroaki Ito; Haruhiro Inoue; Haruo Ikeda; Manabu Onimaru; Akira Yoshida; Toshihisa Hosoya; Kosuke Sudo; Nikolas Eleftheriadis; Roberta Maselli; Chiyo Maeda; Yoko Wada; Norimasa Sando; Shigeharu Hamatani; Shin-ei Kudo
Journal:  J Exp Clin Cancer Res       Date:  2011-12-29

6.  Transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND-study).

Authors:  Frank J C van den Broek; Eelco J R de Graaf; Marcel G W Dijkgraaf; Johannes B Reitsma; Jelle Haringsma; Robin Timmer; Bas L A M Weusten; Michael F Gerhards; Esther C J Consten; Matthijs P Schwartz; Maarten J Boom; Erik J Derksen; A Bart Bijnen; Paul H P Davids; Christiaan Hoff; Hendrik M van Dullemen; G Dimitri N Heine; Klaas van der Linde; Jeroen M Jansen; Rosalie C H Mallant-Hent; Ronald Breumelhof; Han Geldof; James C H Hardwick; Pascal G Doornebosch; Annekatrien C T M Depla; Miranda F Ernst; Ivo P van Munster; Ignace H J T de Hingh; Erik J Schoon; Willem A Bemelman; Paul Fockens; Evelien Dekker
Journal:  BMC Surg       Date:  2009-03-13       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.